Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Evaluation of a Standard Treatment Regimen of Anti-tuberculosis Drugs for Patients With MDR-TB (STREAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02409290
Recruitment Status : Recruiting
First Posted : April 6, 2015
Last Update Posted : March 12, 2019
Sponsor:
Collaborators:
Medical Research Council
Institute of Tropical Medicine, Belgium
London School of Hygiene and Tropical Medicine
Rede TB
Information provided by (Responsible Party):
IUATLD, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : April 2021
  Estimated Study Completion Date : June 2022
Publications of Results:
Other Publications:

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):